These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2865601)

  • 1. HTLV-III antibody in Edinburgh drug addicts.
    Peutherer JF; Edmond E; Simmonds P; Dickson JD; Bath GE
    Lancet; 1985 Nov; 2(8464):1129-30. PubMed ID: 2865601
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-III antibody among Italian drug addicts.
    Ferroni P; Geroldi D; Galli C; Zanetti AR; Cargnel A
    Lancet; 1985 Jul; 2(8445):52-3. PubMed ID: 2861509
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid spread of HTLV-III infection among drug addicts in Italy.
    Angarano G; Pastore G; Monno L; Santantonio T; Luchena N; Schiraldi O
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866362
    [No Abstract]   [Full Text] [Related]  

  • 4. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 5. HTLV-III antibodies in drug addicts in Spain.
    Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L
    Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 9. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 11. HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.
    Follett EA; McIntyre A; O'Donnell B; Clements GB; Desselberger U
    Lancet; 1986 Feb; 1(8478):446-7. PubMed ID: 2868365
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of anti-HTLV-III/LAV antibody by enzyme-linked immunosorbent assay in high-risk individuals in Switzerland 1974-1985.
    Stroun J; Graf I; Frei PC
    Eur J Clin Microbiol; 1985 Dec; 4(6):583-6. PubMed ID: 3004980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-III antibody in Swiss and English intravenous drug abusers.
    Mortimer PP; Vandervelde EM; Jesson WJ; Pereira MS; Burkhardt F
    Lancet; 1985 Aug; 2(8452):449-50. PubMed ID: 2863476
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HTLV-III antibody incidence.
    Goldbaum J
    Med J Aust; 1985 Sep; 143(6):261-2. PubMed ID: 2993832
    [No Abstract]   [Full Text] [Related]  

  • 18. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.
    Fuchs D; Blecha HG; Deinhardt F; Dierich MP; Goebel FD; Hengster P; Hinterhuber H; Schoenitzer D; Traill K; Wachter H
    Lancet; 1985 Jun; 1(8444):1506. PubMed ID: 2861431
    [No Abstract]   [Full Text] [Related]  

  • 19. HTLV-III/LAV-antibody-positive soldiers in Berlin.
    James JJ; Morgenstern MA; Hatten JA
    N Engl J Med; 1986 Jan; 314(1):55-6. PubMed ID: 2999600
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
    Robert-Guroff M; Weiss SH; Giron JA; Jennings AM; Ginzburg HM; Margolis IB; Blattner WA; Gallo RC
    JAMA; 1986 Jun; 255(22):3133-7. PubMed ID: 3009910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.